CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video at Investors.com - Trump Tariffs Are Central To President's Policy Shake-Up ...

In view of the company’s very good performance, the Supervisory Board of Knorr-Bremse AG renewed the contract of CEO Marc Llistosella by five years at the end of January 2025, thus strengthening ...

Interpublic recently signed an advertising agreement with the platform; other agencies are also in negotiations.

CVS Health has named Ed DeVaney president of the company's CVS Caremark pharmacy benefits manager business, CVS announced this week. DeVaney ascends to the top post after having been named interim ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president ...